Skip to content

Clinical trials

Phase 3 Schizophrenia trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 3 Country / region: Australia Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20082
20104
20111
20123
20131
20171
20211
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
FORUM Pharmaceuticals Inc3
Janssen Research & Development, LLC3
AstraZeneca2
Boehringer Ingelheim2
Hoffmann-La Roche2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Bayside Health1
Eli Lilly and Company1
Karuna Therapeutics, Inc., a Bristol Myers Squibb company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia17
Cognition Disorders3
Psychotic Disorders2
Autistic Disorder1
Disease1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.